1.Epitope mapping of hepatitis C virus non-structure protein 5 from a 7 peptide phage library by using immobilized specific monoclonal antibody.
Yan Wei ZHONG ; Jun CHENG ; Gang WANG ; Xiao Jun TIAN ; Xinhua CHEN ; Yan LIU ; Li LI ; Ling Xia ZHANG ; Ju Mei CHEN
Chinese Journal of Hepatology 2002;10(4):266-268
OBJECTIVETo screen HCV NS5 mimotopes by using monoclonal antibody and phage peptide library.
METHODSBy using HCV NS5 monoclonal antibody as selective molecule, a 7 peptide phage library was biopanned and positive clones were selected by ELISA, competition assay and DNA sequencing.
RESULTSTwelve positive clones were chosen for DNA sequencing. From the experiment and sequencing comparison results, one epitope was confirmed as the mimotope of HCV NS5.
CONCLUSIONSHCV mimotope is obtained by phage peptide library screening. The result provides a new approach for HCV therapy and vaccine development.
Amino Acid Sequence ; Antibodies, Monoclonal ; immunology ; Enzyme-Linked Immunosorbent Assay ; Epitope Mapping ; Hepatitis C ; therapy ; Peptide Library ; Viral Nonstructural Proteins ; chemistry ; genetics ; immunology ; Viral Vaccines ; immunology
2.Identification of peptide mimotopes of an abroad-spectrum neutralizing epitope of highly pathogenic avian influenza hemagglutinin.
Hui-Juan SONG ; Wen-Xin LUO ; Zhen-Hua ZHENG ; Ying-Wei CHEN ; Yi-Xin CHEN ; Zi-Min CHEN ; Jun ZHANG ; Ning-Shao XIA
Chinese Journal of Virology 2008;24(6):421-426
A monoclonal antibody (8H5), which showed strong neutralization activity against 33 strains of H5N1 viruses isolated from hosts at various regions from 2002 to 2006, was characterized in our lab recently. This result indicated the presence of highly conserved neutralizing site on hemagglutinin (HA) of various H5N1 subtypes. In the present study, the peptide phage display technique was applied to generate mimotope of the conserved neutralizing epitope recognized by 8H5 mAb. Five peptides displayed on phage were identified to specifically bind to 8H5 mAb. One of the five peptides, 123, was further displayed on the virus-like particle assembled from aa 1-149 fragment of HBcAg. The chimeric particle HBc-T123 conserved the specific binding to 8H5 mAb, and competed with H5N1 viruses for 8H5 mAb. The antiserum induced by HBc-T123 intensively stained on SF21 cells infected by recombinant baculovirus containing HA gene of YU22 virus, indicating the production of cross-reactive antibody to H5N1 HA.
Amino Acid Sequence
;
Animals
;
Antibodies, Monoclonal
;
immunology
;
Epitopes
;
chemistry
;
genetics
;
immunology
;
Hemagglutinin Glycoproteins, Influenza Virus
;
chemistry
;
genetics
;
immunology
;
Humans
;
Influenza A Virus, H5N1 Subtype
;
chemistry
;
genetics
;
immunology
;
Influenza, Human
;
virology
;
Mice
;
Mice, Inbred BALB C
;
Molecular Sequence Data
;
Peptide Library
3.Study on methods for quality control of recombinant human neu epitope peptide 12.
Hong JI ; Jun-zhi WANG ; Chun-ming RAO ; Yi ZHANG ; Min WANG
Acta Pharmaceutica Sinica 2004;39(5):359-362
AIMTo establish methods and requirements for the quality control of recombinant human neu epitope peptide 12.
METHODSBiological activity of recombinant human neu epitope peptide 12 was evaluated in FVB/N transgenic mice (TgN MMTV neu 202 Mul, Jackson Lab., USA) administered with samples. The percentage of antibody-positive mice detected by ELISA was used in the biological activity evaluation. The peptide map was performed by peptic digestion. The antigen content was determined by SEC-HPLC.
RESULTS AND CONCLUSIONThe quality control methods, such as biological activity, peptide map, antigen content, and the requirements for the quality control of recombinant human neu epitope peptide 12 were established. The established methods and requirements were already used for the quality control of recombinant human neu epitope peptide 12 products.
Animals ; Antibodies, Monoclonal ; analysis ; Biotechnology ; methods ; Epitopes ; analysis ; chemistry ; immunology ; Female ; Genes, erbB-2 ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Transgenic ; Peptide Fragments ; chemistry ; immunology ; Peptide Mapping ; Quality Control ; Receptor, ErbB-2 ; analysis ; chemistry ; immunology ; Recombinant Fusion Proteins ; analysis ; chemistry ; immunology ; Technology, Pharmaceutical ; standards
4.Studies on the changes of c-fos protein in spinal cord and neurotransmitter in dorsal root ganglion of the rat with an experimental peripheral neuropathy.
Won Taek LEE ; Min Kyun SOHN ; Seung Hwa PARK ; Soo Kyung AHN ; Jong Eun LEE ; Kyung Ah PARK
Yonsei Medical Journal 2001;42(1):30-40
Animal models for human chronic pain syndromes have been developed and widely used for pain research. One of these neuropathic pain models by Kim and Chung (1992) has many advantages for operation and pain elicitation. In this neuropathic model we have examined the c-fos protein, substance P, CGRP immunoreactivity in dorsal root ganglia and dorsal horn. 50 Sprague-Dawley rats were used for this study. L5 and L6 spinal nerves were ligated tightly to produce the neuropathic pain model. After 2, 4, 8, 16, and 24 hours and 1 week of surgery, rats were anesthetized and sacrificed by perfusion. After confirmation of the roots transected by the surgery, the L5 and L6 dorsal root ganglions and spinal cord were removed and processed for immunohistochemistry. All tissue sections were immunohistochemically stained for substance P, CGRP and c-fos using the peroxidase-antiperoxidase (PAP) method. The number of immunostained substance P and CGRP dorsal root ganglion cells and c-fos immunoreactive dorsal horn cells were counted and analyzed statistically with Mann-Whitney U test. The results are as follows. The number of c-fos protein immunoreactive neurons in the superficial layer of dorsal horn were increased markedly 2 hours after operation, and gradually decreased to normal level 1 week after operation. The number of c-fos protein immunoreactive neurons in the deep layer of the dorsal horn gradually increased to a peak 24 hours after operation, then decreased to the normal level 1 week after operation. The number of substance P and CGRP immunoreactive L5 and L6 dorsal root ganglion neurons were decreased markedly 1 week after the pain model operation. In conclusion, after neuropathic pain model operation, c-fos proteins were immediately expressed in the superficial layer of spinal dorsal horn, thereafter c-fos proteins in the deep layer of spinal dorsal horn were expressed. CGRP and substance P immunoreactive neurons in DRG were decreased markedly 1 week after neuropathic pain model operation. These decrements do not coincide with the other chronic pain models, which show great increases in these pain transmitting substances. Therefore, the relationship between pain and c-fos, SP and CGRP should be investigated further.
Animal
;
Calcitonin Gene-Related Peptide/analysis*
;
Ganglia, Spinal/chemistry*
;
Immunohistochemistry
;
Neurotransmitters/analysis*
;
Pain/metabolism*
;
Peripheral Nervous System Diseases/metabolism*
;
Proto-Oncogene Proteins c-fos/analysis*
;
Rats
;
Rats, Sprague-Dawley
;
Spinal Cord/chemistry*
;
Substance P/analysis*
5.Correlation of coagulation indicators with inflammatory markers for sepsis in the patients with hematological malignancies.
Yang FU ; Hong JIANG ; Li-Xin LI ; Jie CHEN ; Qian NIU ; Ruo-Xu LI
Journal of Experimental Hematology 2014;22(5):1381-1385
This study was aimed to investigate the correlation of coagulation indicators [prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (FIB), antithrombinIII (ATIII), D-dimer (D-D) levels] with inflammatory markers [procalcitonin (PCT), C reactive protein (CRP), interleukin-6 (IL-6), serum amyloid A (SAA)] for sepsis in hematologic malignancy patients. A total of 326 febrile in patients with hematologic diseases from 2062 patients in West China Hospital, Sichuan University from March 2011 to April 2013 were retrospectively analyzed. The patients were divided into sepsis group(n = 72), non-sepsis group(n = 176) and non-sepsis with low Alb group (n = 78) according to blood culture. The results showed that the values of PT, APTT, D-dimer, Plt in sepsis group were higher than those in non-sepsis group, and the difference between them was statistically significant. While the ATIII level in the sepsis group was lower than that in non-sepsis group, and the difference between them was statistically significant (P < 0.05). And the four inflammatory biomarkers in the sepsis patients were higher than those in non-sepsis patients (P < 0.05). TT and FIB level were not significantly different (P > 0.05). There was not a significant difference in these indicators between non-sepsis group and non-sepsis with low Alb group. The correlation analysis suggested that the level of PCT positively correlated with APTT, D-dimer level (P < 0.05); and negatively correlated with the ATIII (P < 0.05). It is concluded that sepsis results in the concurrent activation of inflammatory and procoagulant pathways. The hematologic malignancy patients with sepsis have an obviously higher systemic inflammatory response, and accompanied with coagulation dysfunction.
Biomarkers
;
Blood Coagulation
;
C-Reactive Protein
;
Calcitonin
;
Calcitonin Gene-Related Peptide
;
Fibrin Fibrinogen Degradation Products
;
Hematologic Neoplasms
;
chemistry
;
complications
;
Humans
;
Interleukin-6
;
Partial Thromboplastin Time
;
Protein Precursors
;
Retrospective Studies
;
Sepsis
;
complications
;
Serum Amyloid A Protein
;
Thrombin Time
6.Effects of polypeptides from HCV core region on the function of cytotoxic T cells.
Qiaoyu MA ; Yuming WANG ; Fei HAO
Chinese Journal of Hepatology 2002;10(6):426-428
OBJECTIVETo investigate the pathogenesis of cytotoxic T cell (CTL) dysfunction in patients with HCV infection.
METHODSBALB/c mice were immunized by subcutaneous injection of polypeptides from HCV core region, and the CTL activity of mouse spleen cells was detected by the LDH release test. Two polypeptides which can enhance CTL function and two polypeptides which can inhibit CTL function were selected and cross-combined. BALB/c mice were immunized using the combined polypeptides and the CTL activities were detected afterwards.
RESULTSCTL activity was inhibited by CPA9 (39-74 amino acids), CPB7 (67-76 amino acids) and CPB8 (71-80 amino acids), and promoted by CPA10 (5-23 amino acids), CPB6 (63-72 amino acids) and CPB2 (131-140 amino acids). Using single factor analysis of variance, the CTL activity in the mice could be enhanced by polypeptides from the HCV core region, CPB2+CPB8, CPB6+CPB8, respectively. There was no obvious difference between CPB2+CPB7, CPB6+CPB7 and negative control.
CONCLUSIONSCPA9, CPB7, and CPB8, the 3 polypeptides from HCV core region play an inhibition role and CPA10, CPB6, and CPB2 play an enhancement role in CTL activity in mice. The inhibition and enhancement functions of the polypeptides from HCV core region interact each other.
Animals ; Cytotoxicity Tests, Immunologic ; Cytotoxicity, Immunologic ; drug effects ; Mice ; Mice, Inbred BALB C ; Peptide Fragments ; administration & dosage ; immunology ; Spleen ; cytology ; drug effects ; immunology ; T-Lymphocytes, Cytotoxic ; cytology ; immunology ; Viral Core Proteins ; administration & dosage ; chemistry ; immunology
7.Peptide mapping of H-2d restricted T-cell epitope against six antigens of HIV-1 subtype B'/C by ELISPOT assay.
Xiang-rong QI ; Ying-ying GAO ; Rou-jian LU ; Yao DENG ; Xin MENG ; Wen-jie TAN ; Li RUAN
Chinese Journal of Virology 2011;27(1):34-43
The purpose is to screen and identify the specific H-2d restricted T-cell epitopes. These epitopes are used to investigate the cellular immune response of BALB/c (H-2d) mice immunized with a HIV-1 vaccine which expresses six antigens of gp160, gag, pol, rev, tat and nef of HIV subtype B'/C. A replicating DNA vaccine and a non-replicating recombinant vaccinia virus vector, both expressing the six antigens mentioned above, were used to immune BALB/c (H-2d) mice in a prime-boost regiment. The six peptide libraries of HIV B'/C corresponding respectively to the six complete antigens were pooled according to a designed matrix format and used to test for IFN-gamma production from splenocytes of immunized mice by an enzyme-linked immunospot (IFN-gamma ELISPOT) assay. The ELISPOT data indicated that two of seven Gag-specific T-cell epitope peptides were identified to be the novel epitopes. One of three Pol-specific T-cell epitope is unreported. One novel epitope was confirmed in two gp160-specific T-cell epitope peptides. One Nef-specific T-cell epitope was identified. Three Tat-specific T-cell epitope peptides were continuous sequences in Tat peptide library and all contained either complete or partial sequence reported. Rev-specific T-cell epitope was not be found. The specific T-cell epitopes (H-2d restricted) were identified by IFN-7 ELISPOT assay, which could be used to detect the cellular immune response of BALB/c mice immunized with the HIV-1 vaccine expressing six antigens of gp160, gag, pol, rev, tat and nef of HIV subtype B'/C.
Amino Acid Sequence
;
Animals
;
Enzyme-Linked Immunospot Assay
;
methods
;
Epitopes, T-Lymphocyte
;
chemistry
;
genetics
;
immunology
;
Female
;
H-2 Antigens
;
chemistry
;
genetics
;
immunology
;
HIV Antigens
;
chemistry
;
genetics
;
immunology
;
HIV Infections
;
immunology
;
virology
;
HIV-1
;
classification
;
genetics
;
immunology
;
Histocompatibility Antigen H-2D
;
Humans
;
Mice
;
Mice, Inbred BALB C
;
Molecular Sequence Data
;
Peptide Mapping
;
methods
8.Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties.
Chong Woo BAE ; Sung Hoon CHUNG ; Yong Sung CHOI
Yonsei Medical Journal 2016;57(1):203-208
PURPOSE: Pulmonary surfactant (PS) replacement has been the gold standard therapy for neonatal respiratory distress syndrome; however, almost all commercial PSs contain animal proteins. We prepared a synthetic PS by using a human surfactant protein (SP) analog and evaluated its in vitro properties. MATERIALS AND METHODS: A peptide sequence (CPVHLKRLLLLLLLLLLLLLLLL) of human SP-C was chosen to develop the peptide analog (SPa-C). The new synthetic SP-C PS (sSP-C PS) was synthesized from SPa-C, dipalmitoyl phosphatidylcholine, phosphatidyl glycerol, and palmitic acid. Physical properties of the sSP-C PS were evaluated by measuring the maximum and minimum surface tensions (STs), surfactant spreading, and adsorption rate. In addition, we recorded an ST-area diagram. The data obtained on sSP-C PS were subsequently compared with those of purified natural bovine surfactant (PNBS), and the commercial product, Surfacten(R). RESULTS: The sSP-C PS and Surfacten(R) were found to have maximum ST values of 32-33 mN/m, whereas that of PNBS was much lower at 19 mN/m. The minimum ST values of all three products were less than 10 mN/m. The values that were measured for the equilibrium ST of rapidly spreading sSP-C PS, Surfacten(R), and PNBS were 27, 27, and 24 mN/m, respectively. The surface adsorptions were found to be the same for all three PSs (20 mN/m). ST-area diagrams of sSP-C PS and Surfacten(R) revealed similar properties. CONCLUSION: In an in vitro experiment, the physical properties exhibited by sSP-C PS were similar to those of Surfacten(R). Further study is required to evaluate the in vivo efficacy.
1,2-Dipalmitoylphosphatidylcholine/analogs & derivatives
;
Adsorption
;
Amino Acid Sequence/*genetics
;
Animals
;
C-Peptide/*chemistry
;
Cattle
;
Humans
;
Infant, Newborn
;
Pulmonary Surfactant-Associated Protein C/*chemical synthesis/pharmacology
;
Pulmonary Surfactants/*chemical synthesis/pharmacology
;
Respiratory Distress Syndrome, Newborn/*drug therapy
;
*Surface Properties
;
*Surface Tension
;
Surface-Active Agents
9.Effects of acidic oligose on differentially expressed genes in the mice model of Alzheimer's disease by microarray.
Ling-na KONG ; Mei-yu GENG ; Liang MU ; Xian-liang XIN ; Nan YANG ; Ping-ping ZUO
Acta Pharmaceutica Sinica 2005;40(12):1105-1109
AIMTo investigate the molecular mechanism of protective effect of acidic oligose 971 on Alzheimer's disease mouse model by using microarray.
METHODSBalb/c mice were randomly divided into control group, beta-AP(25-35) i.c.v. injected group and 971-treated group. The learning-memory ability of mice was tested by Morris water maze experiment. Total RNA of the cerebral cortex was extracted from the mice of each group. cDNA microarrays containing 1176 genes were used to investigate the gene expression pattern of each group. Expressions of 5 genes were randomly selected for further confirmation by RT-PCR.
RESULTSIcv injection of beta-AP(25-35) caused significant impairments in spatial and working memory performances of mice in Morris water maze and which were relieved by the treatment of 971. Up- and down- regulated genes were 19 and 12 in beta-AP(25-35)-injected group vs control group, respectively. Up- and down- regulated genes were 13 and 4, respectively, in 971-treated group vs beta-AP(25-35)-injected group. RT-PCR results indicated that 5 genes showed identical results to that of the microarray.
CONCLUSIONThe protective effect of 971 on learning and memory ability of beta-AP(25-35)-treated mouse may be related to the expression changes of genes involved in cell cycle, DNA repair, nerve growth, synaptic plasticity and immune response, etc.
Alzheimer Disease ; chemically induced ; genetics ; physiopathology ; Amyloid beta-Peptides ; Animals ; Gene Expression Profiling ; Male ; Maze Learning ; drug effects ; Mice ; Mice, Inbred BALB C ; Neuroprotective Agents ; isolation & purification ; pharmacology ; Oligonucleotide Array Sequence Analysis ; Oligosaccharides ; isolation & purification ; pharmacology ; Peptide Fragments ; Phaeophyta ; chemistry ; Random Allocation
10.A Case of Polyglandular Autoimmune Syndrome.
Chul Hee KIM ; Hong Kyu KIM ; Joong Yeol PARK ; Young Ki SONG ; Ki Soo KIM ; Kyo Sang YOO
Journal of Korean Society of Endocrinology 1997;12(4):672-676
The polyglandular autoimmune syndrome is constellation of multiple endocrine insufficiencies often associated with diseases of nonendocrine organs occurring in individual patients and their families. In 1980, Neufeld classified this syndrome into three major types. Type II is characterized by adrenocortical insufficiency, autoimmune thyroiditis, and insulin-dependent diabetes mellitus. We experienced a case characterized by adrenocortical insufficiency, autoimmune thyroiditis, and ovarian failure and report with the review of the literature. A 38-year-old woman visited our clinic because of progressing brown colored pigmentation of skin and mucosa which is developed a year ago. Nine years ago prior to visit, amenorrhea was developed after right oophrectomy. Three years ago, she revealed feature of hyperthyroidism such as palpitation, loss of body weight (8kg/1-2years), heat intolerance, and sweating, so received antithyroid therapy for 14 months. Brown colored pigmentation of skin and mucosa, especially scar and gingiva, has been progressively aggravated during last year. She had no past or family history of other endocrine disease. Diffuse pigmentation of skin, loss of axillary and pubic hair, and diffuse enlargement of both thyroid glands were shown on physical examination. Blood cell count, serum chemistry and blood sugar test were all within normal range. Basal hormone levels were T3-uptake 29.7% (30~40), T3 153 ng/dL (85~185), T4 7.5ug/dL (5.5~11.5), TSH 2.4 IU (0.34~3.5), anti-TG antibody <100 U/mL (0~100), anti-microsome antibody <50 U/mL (0~100), TBII (thyrotropin binding inhibiting immunoglobulin) 2.2% ( (-15)~15), ACTH 989 pg/mL (0~37), cortisol 0.1 ug/dL (5~25), renin 7.1ng/mL/hr (1~2.5), aldosterone 81.0pg/mL (50~194), LH 115.2 mIU/mL (0.6~16.8), FSH 122 mIU/mL (1.6~19.0), and estradiol <10.0pg/mL (30~120). In ACTH stimulation test, levels of basal cortisol, 30 minutes, and 60 minutes were <0.1, <0.1, and <0.1 g/dL respectively. And, in glucagon stimulation test, levels of basal C-peptide, 5 minutes, 10 minutes, and 15 minutes were 0.9, 5,1, 6.3, and 5.5 ng/dL respectively. Thyroid scan showed diffuse enlargement of bilateral thyroid glands and pelvic ultrasonogram showed atrophy of left ovary. We administered corticosteroid, estrogen, and progesterone which were deficient to the patient, and has followed up the clinical course of the patient.
Adrenocorticotropic Hormone
;
Adult
;
Aldosterone
;
Amenorrhea
;
Atrophy
;
Blood Cell Count
;
Blood Glucose
;
Body Weight
;
C-Peptide
;
Chemistry
;
Cicatrix
;
Diabetes Mellitus, Type 1
;
Endocrine System Diseases
;
Estradiol
;
Estrogens
;
Female
;
Gingiva
;
Glucagon
;
Hair
;
Hot Temperature
;
Humans
;
Hydrocortisone
;
Hyperthyroidism
;
Mucous Membrane
;
Ovary
;
Physical Examination
;
Pigmentation
;
Progesterone
;
Reference Values
;
Renin
;
Skin
;
Sweat
;
Sweating
;
Thyroid Gland
;
Thyroiditis, Autoimmune
;
Ultrasonography